Latest News about VALN

Recent news which mentions VALN

...

4 5 6 7 8 9 10 11 Next >

How To Attend Valneva Q1 2022 Earnings Conference Call

May 03, 2022

Why Pfizer Stock Rose Today While the Market Tanked

April 26, 2022

Valneva - Pfizer Post Encouraging Data From Lyme Disease Vaccine Candidate

April 26, 2022

The Daily Biotech Pulse: Protagonist's Ulcerative Colitis Study Disappoints, Gilead's Remdesivir Approved For Pediatric COVID-19 Patients, FDA Gives Nod To Gamida's Cell Therapy Trial, Fast Track Tag

April 26, 2022

China’s latest COVID outbreak spooks investors, and U.S. cases and hospitalizations are rising again

April 25, 2022

12 Health Care Stocks Moving In Monday's Pre-Market Session

April 25, 2022

Valneva Receives More Questions From European Regulator For Its COVID-19 Vaccine, Shares Fall

April 25, 2022

Britain Approves Moderna's COVID-19 Vaccine For Kids Aged 6-11 Years

April 14, 2022

The Daily Biotech Pulse: Pfizer-BioNTech COVID-19 Booster Data In Kids, Regeneron's COVID-19 Therapy Decision Pushed, Protagonist's Rusfertide Breakthrough Tag Update And More

April 14, 2022

Valneva Shares Jump As Its COVID-19 Vaccine Receives Conditional Approved In UK

April 14, 2022

Earnings Scheduled For March 24, 2022

March 24, 2022

European Recommendation On Valneva's COVID-19 Shot Pushed Into April

March 11, 2022

The Daily Biotech Pulse: Valneva Gains On COVID Shot Regulatory Update, Lucira Health And Clearside Jump On Earnings, BeiGene Drug Snags Approval In China

March 11, 2022

Read Why Valneva's Stock Gained 7% Today

March 08, 2022

The Daily Biotech Pulse: Moderna Outlines Steps For mRNA Tech Advancement, Voyager-Novartis Strike Licensing Deal, Valneva Reports Positive Chikungunya Shot Readout

March 08, 2022

76 Biggest Movers From Yesterday

March 08, 2022

46 Stocks Moving In Monday's Mid-Day Session

March 07, 2022

42 Stocks Moving in Monday's Pre-Market Session

March 07, 2022

The Daily Biotech Pulse: Legend Biotech, CTI Biopharma Receive FDA Approvals, AbbVie Announces Delay In Skyrizi Review, Editas Gains On CRISPR Patent Resolution

March 01, 2022

The Daily Biotech Pulse: Lilly's Jardiance Gets Nod For Heart Failure, Pulmatrix Announces Reverse Split, Reata Awaits FDA Decision

February 25, 2022

Valneva Secures £20M From Scottish Enterprise For Vaccine Development

February 22, 2022

Valneva - Pfizer Choose Three-Dose Schedule For Lyme Vaccine Candidate Moving Forward

February 04, 2022

The Daily Biotech Pulse: Sanofi, Bristol-Myers Squibb Gain On Earnings, Valneva-Pfizer Tout Positive Lyme Disease Vaccine Data, UNITY Biotech Restructures

February 04, 2022

The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation

February 03, 2022

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday

February 03, 2022

Why Are Valneva Shares Rising Today Premarket?

February 03, 2022

The Daily Biotech Pulse: ImmunityBio Reports Positive Readout, Valneva Starts Late-Stage Chikungunya Vaccine Study, Sio Gene Shelves Parkinson's Program

February 01, 2022

Valneva Kickstarts Phase 3 Trial Of Chikungunya Vaccine Candidate In Adolescents

February 01, 2022

Valneva Advances Booster Phase Of Its Cov-Compare COVID-19 Vaccine Trial

January 25, 2022

48 Biggest Movers From Yesterday

January 21, 2022

...

4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.